These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1906344)

  • 1. Transcriptional deregulation of myc in IgH/myc 6;7 translocation carrying rat immunocytomas.
    Axelson H; Pear WS; Panda CK; Bazin H; Klein G; Sümegi J
    Genes Chromosomes Cancer; 1991 Mar; 3(2):142-8. PubMed ID: 1906344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a locus control region in the immunoglobulin heavy-chain locus that deregulates c-myc expression in plasmacytoma and Burkitt's lymphoma cells.
    Madisen L; Groudine M
    Genes Dev; 1994 Sep; 8(18):2212-26. PubMed ID: 7958890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three exceptional IgH/myc-translocation-carrying rat immunocytomas have breakpoints 50 to 80 kb 5' of c-myc.
    Axelson H; Panda CK; Klein G
    Int J Cancer; 1994 Feb; 56(3):418-21. PubMed ID: 8314330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 6;7 chromosomal translocation in spontaneously arising rat immunocytomas: evidence for c-myc breakpoint clustering and correlation between isotypic expression and the c-myc target.
    Pear WS; Wahlström G; Nelson SF; Axelson H; Szeles A; Wiener F; Bazin H; Klein G; Sümegi J
    Mol Cell Biol; 1988 Jan; 8(1):441-51. PubMed ID: 3122026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of a paused transcription complex from the c-myc P2 promoter of the translocation chromosome in Burkitt's lymphoma cells: implication for the c-myc P1/P2 promoter shift.
    Strobl LJ; Kohlhuber F; Mautner J; Polack A; Eick D
    Oncogene; 1993 Jun; 8(6):1437-47. PubMed ID: 8502472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insertion of c-Myc into Igh induces B-cell and plasma-cell neoplasms in mice.
    Park SS; Kim JS; Tessarollo L; Owens JD; Peng L; Han SS; Tae Chung S; Torrey TA; Cheung WC; Polakiewicz RD; McNeil N; Ried T; Mushinski JF; Morse HC; Janz S
    Cancer Res; 2005 Feb; 65(4):1306-15. PubMed ID: 15735016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NF-kappa B activity is required for the deregulation of c-myc expression by the immunoglobulin heavy chain enhancer.
    Kanda K; Hu HM; Zhang L; Grandchamps J; Boxer LM
    J Biol Chem; 2000 Oct; 275(41):32338-46. PubMed ID: 10931834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breakpoints of Burkitt's lymphoma t(8;22) translocations map within a distance of 300 kb downstream of MYC.
    Zeidler R; Joos S; Delecluse HJ; Klobeck G; Vuillaume M; Lenoir GM; Bornkamm GW; Lipp M
    Genes Chromosomes Cancer; 1994 Apr; 9(4):282-7. PubMed ID: 7519050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant class switching juxtaposes c-myc with a middle repetitive element (LINE) and an IgH intron in two spontaneously arising rat immunocytomas.
    Pear WS; Nelson SF; Axelson H; Wahlström G; Bazin H; Klein G; Sümegi J
    Oncogene; 1988 May; 2(5):499-507. PubMed ID: 3131719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences between Burkitt's lymphomas and mouse plasmacytomas in the immunoglobulin heavy chain/c-myc recombinations that occur in their chromosomal translocations.
    Müller JR; Janz S; Potter M
    Cancer Res; 1995 Nov; 55(21):5012-8. PubMed ID: 7585544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple chromosomal rearrangements in a spontaneously arising t(6;7) rat immunocytoma juxtapose c-myc and immunoglobulin heavy chain sequences.
    Pear WS; Ingvarsson S; Steffen D; Münke M; Francke U; Bazin H; Klein G; Sümegi J
    Proc Natl Acad Sci U S A; 1986 Oct; 83(19):7376-80. PubMed ID: 3020544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The intron enhancer of the immunoglobulin kappa gene activates c-myc but does not induce the Burkitt-specific promoter shift.
    Polack A; Strobl L; Feederle R; Schweizer M; Koch E; Eick D; Wiegand H; Bornkamm GW
    Oncogene; 1991 Nov; 6(11):2033-40. PubMed ID: 1945409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Level of MYC overexpression in pediatric Burkitt's lymphoma is strongly dependent on genomic breakpoint location within the MYC locus.
    Wilda M; Busch K; Klose I; Keller T; Woessmann W; Kreuder J; Harbott J; Borkhardt A
    Genes Chromosomes Cancer; 2004 Oct; 41(2):178-82. PubMed ID: 15287031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allele-specific activation of the c-myc gene in an atypical Burkitt's lymphoma carrying the t(2;8) chromosomal translocation 250 kb downstream from c-myc.
    Tachibana K; Takayama N; Matsuo K; Kato S; Yamamoto K; Ohyama K; Umezawa A; Takano T
    Gene; 1993 Feb; 124(2):231-7. PubMed ID: 8444346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of two distinct MYC breakpoint clusters and their association with various IGH breakpoint regions in the t(8;14) translocations in sporadic Burkitt-lymphoma.
    Busch K; Keller T; Fuchs U; Yeh RF; Harbott J; Klose I; Wiemels J; Novosel A; Reiter A; Borkhardt A
    Leukemia; 2007 Aug; 21(8):1739-51. PubMed ID: 17541401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variable breakpoints in Burkitt lymphoma cells with chromosomal t(8;14) translocation separate c-myc and the IgH locus up to several hundred kb.
    Joos S; Falk MH; Lichter P; Haluska FG; Henglein B; Lenoir GM; Bornkamm GW
    Hum Mol Genet; 1992 Nov; 1(8):625-32. PubMed ID: 1301171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The amino-terminal phosphorylation sites of C-MYC are frequently mutated in Burkitt's lymphoma lines but not in mouse plasmacytomas and rat immunocytomas.
    Axelson H; Henriksson M; Wang Y; Magnusson KP; Klein G
    Eur J Cancer; 1995 Nov; 31A(12):2099-104. PubMed ID: 8562172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new variant 15; 16 translocation in mouse plasmacytoma leads to the juxtaposition of c-myc and immunoglobulin lambda.
    Axelson H; Panda CK; Silva S; Sugiyama H; Wiener F; Klein G; Sumegi J
    Oncogene; 1991 Dec; 6(12):2263-70. PubMed ID: 1766673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of immunoglobulin kappa elements in c-myc activation.
    Hörtnagel K; Mautner J; Strobl LJ; Wolf DA; Christoph B; Geltinger C; Polack A
    Oncogene; 1995 Apr; 10(7):1393-401. PubMed ID: 7731690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variable IgH chain enhancer activity in Burkitt's lymphomas suggests an additional, direct mechanism of c-myc deregulation.
    Jain VK; Judde JG; Max EE; Magrath IT
    J Immunol; 1993 Jun; 150(12):5418-28. PubMed ID: 8515068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.